Clinical Trial Update: Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 clinical trial evaluated a conditioning regimen using Clofarabine and Busulfan for hematologic malignancies, including leukemia and lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Leukemia
• Multiple Myeloma
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma

Drugs mentioned

• BUSULFAN (Busulfan)
• Clofarabine (clofarabine)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Leukemia, Hodgkin Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-01-13